Skip to main content

Table 2 Summary of results of salvage treatment (n = 45)

From: Cancer-specific and overall survival in patients with recurrent prostate cancer who underwent salvage extended pelvic lymph node dissection

Follow-up (months), mean (SD) 42.7 (±20.8)
Median PSA-nadir after salvage ePLND, ng/ml (SD) 4.4 ± 1.5
N-stage after salvage ePLND
N0 (%) 19 (42.2 %)
N1 (%) 26 (58.7 %)
No. of LNs removed (range) 971 (4–76)
Mean no. of LNs removed per patient (SD) 21.6 (±9)
No. of positive LNs (range) 183 (1–42)
No. of positive LNs per patient (range) 4,1 (1–42)
No. of deaths (%) 7 (15.6 %)
Time to death (months), mean (range) 48.8 5–105
BR after salvage ePLND n (% patients) 31 (68.9 %)
BCRF immediately after salvage ePLND (complete BR) n (% patients) 22 (48.9 %)
BCRF during follow-up n (% patients) 33 (73.3 %)
Mean BCRF duration (months) (SD) 31.4 (±19.7)
ADT before salvage ePLND
No. (%) patients
36 (80.0 %)
ADT after salvage ePLND
No. (%) patients
40 (88.9 %)
Bone metastases in follow-up after salvage ePLND
No. (%) patients
10 (22.2 %)